Skip to Content

M I 100 (Imatinib Mesylate 100 mg)

Pill with imprint M I 100 is Orange, Round and has been identified as Imatinib Mesylate 100 mg. It is supplied by Mylan Pharmaceuticals Inc..

Imatinib is used in the treatment of chronic myelogenous leukemia; acute lymphoblastic leukemia; chronic eosinophilic leukemia; dermatofibrosarcoma protuberans; gastrointestinal stromal tumor and belongs to the drug class BCR-ABL tyrosine kinase inhibitors. There is positive evidence of human fetal risk during pregnancy. Imatinib 100 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for M I 100

Imatinib mesylate 100 mg M I 100

Imatinib Mesylate

Imprint
M I 100
Strength
100 mg
Color
Orange
Size
9.00 mm
Shape
Round
Availability
Prescription only
Drug Class
BCR-ABL tyrosine kinase inhibitors
Pregnancy Category
D - Positive evidence of risk
CSA Schedule
Not a controlled drug
Labeler / Supplier
Mylan Pharmaceuticals Inc.
National Drug Code (NDC)
00378-2245
Inactive Ingredients
silicon dioxide, magnesium stearate, microcrystalline cellulose, ferric oxide red, magnesium silicate, titanium dioxide, ferric oxide yellow

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Related Images for "M I 100"

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.